Compare MNC Asia Holding Tbk. (BHIT) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MNC Asia Holding Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? MNC Asia Holding Tbk. trades at Rp26 (market cap 2.24T, 2.08M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: MNC Asia Holding Tbk. is far larger — about 7.2× Diagnos Laboratorium Utama Tbk.'s market cap, and MNC Asia Holding Tbk. is more actively traded (2.08M versus 159.2K). Which is the better fit depends on your goals.
| BHIT | DGNS | |
|---|---|---|
Market Cap | 2.24T | 310.75B |
Volume | 2.08M | 159.2K |
Lot | 20.82K | 1.59K |
Turnover | 53.46M | 34.72M |
Average Price | 25.68 | 218.06 |
Value | 53.46M | 34.72M |
Indicative Equilibrium Price | 26 | 220 |
Indicative Equilibrium Volume | 2.54K | 6 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MNC Asia Holding Tbk.
PT MNC Investama Tbk formerly PT Bhakti Investama Tbk was established on 2 November, 1989 in Surabaya to engage in the capital market business and has fully developed itself into a full financial service business. In 1999, the Company has decided to shift its focus into an investment company. Through several corporate actions, such as restructuring, merger, acquisition and direct investment, the Company has positioned itself as a holding company of several subsidiaries, currently comprising of two strategic investments, namely Media through PT Global Mediacom Tbk and financial services through PT Bhakti Capital Indonesia Tbk. Aside from the two strategic investments, the Company also possesses several investment portfolios that offer attractive growth opportunities, such as PT Global Transport Services, PT Citra Marga Nusaphala Persada Tbk, PT MNC SkyVision and several other investment portfolios.
Read more on BHIT →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
